99 related articles for article (PubMed ID: 27512000)
1. Association of the immunohistochemical detection of gamma-glutamyl transferase expression with clinicopathological findings in postmenopausal women with endometrioid adenocarcinoma of the uterus.
Pitynski K; Ozimek T; Galuszka N; Banas T; Milian-Ciesielska K; Pietrus M; Okon K; Mikos M; Juszczyk G; Sinczak-Kuta A; Stoj A
J Physiol Pharmacol; 2016 Jun; 67(3):395-402. PubMed ID: 27512000
[TBL] [Abstract][Full Text] [Related]
2. SOX-2, but not Oct4, is highly expressed in early-stage endometrial adenocarcinoma and is related to tumour grading.
Pityński K; Banas T; Pietrus M; Milian-Ciesielska K; Ludwin A; Okon K
Int J Clin Exp Pathol; 2015; 8(7):8189-98. PubMed ID: 26339387
[TBL] [Abstract][Full Text] [Related]
3. Expression of maspin in endometrioid adenocarcinoma of endometrium.
Li HW; Leung SW; Chan CS; Yu MM; Wong YF
Oncol Rep; 2007 Feb; 17(2):393-8. PubMed ID: 17203179
[TBL] [Abstract][Full Text] [Related]
4. Membrane expression of TRAIL receptors DR4, DR5, DcR1 and DcR2 in the normal endometrium, atypical endometrial hyperplasia and endometrioid adenocarcinoma: a tissue microarray study.
Gottwald L; Piekarski J; Kubiak R; Szwalski J; Pasz-Walczak G; Sęk P; Spych M; Suzin J; Tyliński W; Jeziorski A
Arch Gynecol Obstet; 2013 Oct; 288(4):889-99. PubMed ID: 23584885
[TBL] [Abstract][Full Text] [Related]
5. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
[TBL] [Abstract][Full Text] [Related]
6. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
[TBL] [Abstract][Full Text] [Related]
7. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
[TBL] [Abstract][Full Text] [Related]
8. Clusterin immunoexpression is associated with early stage endometrial carcinomas.
Al-Maghrabi JA; Butt NS; Anfinan N; Sait K; Sait H; Bajouh O; Khabaz MN
Acta Histochem; 2016 May; 118(4):430-4. PubMed ID: 27079858
[TBL] [Abstract][Full Text] [Related]
9. Expression of Ki-67 as proliferation biomarker in imprint smears of endometrial carcinoma.
Kosmas K; Stamoulas M; Marouga A; Kavantzas N; Patsouris E; Athanassiadou P
Diagn Cytopathol; 2013 Mar; 41(3):212-7. PubMed ID: 21965052
[TBL] [Abstract][Full Text] [Related]
10. DJ-1 in endometrial cancer: a possible biomarker to improve differential diagnosis between subtypes.
Morelli M; Scumaci D; Di Cello A; Venturella R; Donato G; Faniello MC; Quaresima B; Cuda G; Zullo F; Costanzo F
Int J Gynecol Cancer; 2014 May; 24(4):649-58. PubMed ID: 24614826
[TBL] [Abstract][Full Text] [Related]
11. Interferon regulatory factor-1 expression in human uterine endometrial carcinoma.
Kuroboshi H; Okubo T; Kitaya K; Nakayama T; Daikoku N; Fushiki S; Honjo H
Gynecol Oncol; 2003 Nov; 91(2):354-8. PubMed ID: 14599866
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of Musashi-1 in endometrioid adenocarcinoma.
Ma L; Xu YL; Ding WJ; Shao HF; Teng YC
Int J Clin Exp Pathol; 2015; 8(5):4564-72. PubMed ID: 26191146
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratin 19 expression in normal endometrium and in low-grade endometrioid adenocarcinoma of the endometrium.
Stewart CJ; Crook ML; Lacey J; Louwen K
Int J Gynecol Pathol; 2011 Sep; 30(5):484-91. PubMed ID: 21804393
[TBL] [Abstract][Full Text] [Related]
14. Rap1GAP inhibits tumor progression in endometrial cancer.
Tamate M; Tanaka R; Osogami H; Matsuura M; Satohisa S; Iwasaki M; Saito T
Biochem Biophys Res Commun; 2017 Apr; 485(2):476-483. PubMed ID: 28196746
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.
Nishimura Y; Watanabe J; Jobo T; Kato N; Fujisawa T; Kamata Y; Kuramoto H
Anticancer Res; 2004; 24(4):2185-91. PubMed ID: 15330159
[TBL] [Abstract][Full Text] [Related]
16. Serum amyloid A: a novel biomarker for endometrial cancer.
Cocco E; Bellone S; El-Sahwi K; Cargnelutti M; Buza N; Tavassoli FA; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Cancer; 2010 Feb; 116(4):843-51. PubMed ID: 20041483
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of HOMER2 predicts better outcome in low-grade endometrioid endometrial adenocarcinoma.
Mhawech-Fauceglia P; Walia S; Yessaian A; Machida H; Matsuo K; Lawrenson K
Pathology; 2018 Aug; 50(5):499-503. PubMed ID: 29891190
[TBL] [Abstract][Full Text] [Related]
18. miR-497-5p Decreased Expression Associated with High-Risk Endometrial Cancer.
Fridrichova I; Kalinkova L; Karhanek M; Smolkova B; Machalekova K; Wachsmannova L; Nikolaieva N; Kajo K
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374439
[TBL] [Abstract][Full Text] [Related]
19. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
Xiong Y; Xiong YY; Zhou YF
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
